News
PFE
24.93
-1.10%
-0.28
May 9th Options Now Available For Pfizer (PFE)
NASDAQ · 14h ago
Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive
NASDAQ · 14h ago
Healthcare Stocks Sicken as RFK JR Cuts Thousands of Jobs at Health Department
TipRanks · 14h ago
Guru Fundamental Report for PFE
NASDAQ · 16h ago
RFK Jr. reportedly plans 10,000 job cuts in HHS with FDA, CDC, Medicare affected
Seeking Alpha · 17h ago
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
TipRanks · 18h ago
Why Pfizer Is My Largest Healthcare Position
The Motley Fool · 19h ago
WSJ report of probe to have limited impact on Pfizer, says Citi
TipRanks · 19h ago
Trump administration cancels $12 billion in funding to state health departments
Seeking Alpha · 23h ago
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks
Barchart · 1d ago
Strategically Building A $100,000 Dividend Portfolio For Attractive Income And Strong Risk-Adjusted Returns
Seeking Alpha · 1d ago
Pfizer Stock (PFE) Slips as U.S. Probes the Timing of Its COVID-19 Vaccine Results
TipRanks · 1d ago
Pfizer Shares Are Down Today: What's Going On?
Benzinga · 1d ago
Pfizer drops after report on U.S. probe related to its COVID vaccine success
Seeking Alpha · 1d ago
'U.S. Prosecutors Probe Tip About Timing Of Pfizer Vaccine; Claim Came To The U.S. Attorney's Office In Manhattan Via Pfizer Rival GSK' - WSJ
Benzinga · 1d ago
U.S. prosecutors look into claim Pfizer delayed vaccine news, WSJ says
TipRanks · 1d ago
*GSK Scientist Disputes Colleagues' Account
The Wall Street Journal · 1d ago
*U.S. Prosecutors Probe Tip About Pfizer Covid-Vaccine-Results Timing, Sources Say
The Wall Street Journal · 1d ago
*GSK Scientist Allegedly Told Colleagues Pfizer Delayed Results Announcement Until After 2020 Election, Sources Say
The Wall Street Journal · 1d ago
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The Wall Street Journal · 1d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.